Curated GI articles Jan 2nd, 2021: 2020: A year like no other
Curated GI articles Jan 2nd, 2021:
2020: A year like no other
8 predictions for GI in 2021 (Becker’s GI & Endoscopy) Chris Shaver, MD, is the CEO at Birmingham (Ala.) Gastroenterology Associates. Here, he offers eight predictions on the future of the specialty in 2021.
Exact Sciences: 2020 in review (Becker’s GI & Endoscopy)
The company planned to build on its 2019 acquisition of Genomic Health to create a multifaceted diagnostic testing company in 2020, but COVID-19-related disruptions altered the plan for the year.
10 global health issues to track in 2021 (WHO) Speed up access to COVID-19 tests, medicines and vaccines, Provide global leadership on science and data and more.
Why 2 analysts think big things are in store for GI M&A in 2021 (Becker’s ASC Review)
Bill Bolding, senior analyst at Provident and Eric Major, director at Provident, offered insights on the current state of PE investment in GI and made predictions about what 2021 could look like.
Healthcare digital transformation: 5 predictions for 2021 (CIO) The market now favors “digital-first” companies, i.e., those who deliver healthcare primarily as online experiences, especially for ambulatory and low-acuity care needs.
aScope™ Duodeno Coding and Payment Guide (Ambu) George Catinis, MD, medical director at the New Orleans Research Institute, discusses an RNA-FIT colorectal cancer screening test developed by Geneoscopy.
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.